Intervention to Improve Diabetes Outcomes in Older African American Women With Multi-Caregiving Burden
Part of paid clinical trials in Milwaukee, Wisconsin.
- Sponsor
- Medical College of Wisconsin
- Study ID
- NCT04831697
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 40 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- Multi-Caregiving Intervention — BEHAVIORALThe multi-caregiving intervention consists of individual-based, social support, and health educator facilitation and includes: a. Storytelling/sharing of experiences (5 minutes); social support and problem solving (15 minutes); Coping strategies (15 minutes); and Structured Diabetes Education and Skills Training (15 minutes). The last 5 minutes will be used to debrief and review goals.
- Diabetes Enhanced Usual Care Intervention — BEHAVIORALThis is composed of individual-based, health educator-facilitated diabetes education and skills training and general health education and will receive structured diabetes education and skills training as described above (30 minutes) and an additional discussion on general health topics (i.e., back pain, dyspepsia, etc.) (30 minutes).
Study Details
This is a two arm, pilot randomized control trial (RCT) in which 60 African American women (AAW), 40-64 years of age, with HbA1c ≥8% and multi-caregiving responsibilities will be recruited from communities in Milwaukee, Wisconsin and randomized to either: 1) an individual-based, social support, health educator-facilitated intervention to address multi-caregiving responsibilities (n=30), or 2) individual-based, health educator-facilitated diabetes education and skills training and general health education (n=30). All sessions will be delivered via telephone (i.e., landline, mobile device, smart device, etc.) by a health educator (i.e., nurse, social worker, Master's trained health educator) and is comprised of 12 weekly sessions and 3 booster sessions. Each session will last up to 60min. All study assessments will be administered by a Program Assistant at baseline, 3-months, and 6-months.
Key Dates
- Start date
- Dec 14, 2021
- Status verified
- Apr 2026
- Primary completion
- Feb 22, 2024
- Completion
- May 31, 2024
Study Design
- Enrollment
- 60 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Multi-Caregiving InterventionThe multi-caregiving intervention consists of individual-based, social support, and health-educator facilitation and includes: a. Storytelling/sharing of experiences (5 minutes); social support and problem solving (15 minutes); Coping strategies (15minutes); and Structured Diabetes Education and Skills Training (15 minutes). The final 5min will be used for debriefing/reviewing goals.
- Active Comparator: Diabetes Enhanced Usual Care InterventionThis is composed of individual-based, health educator-facilitated diabetes education and skills training and general health education and will receive structured diabetes education and skills training as described above (30 minutes) and an additional discussion on general health topics (i.e., back pain, dyspepsia, etc.) (30 minutes).
Primary Outcome Measure
Mean Change in HbA1c% From Baseline to 6 Months [ Time Frame: Baseline, 6-months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | - |
Find similar trials in Milwaukee, WI
Related Studies
- Role of Autophagy in Type 2 Diabetes Microvascular DysfunctionEARLY_PHASE1 · Recruiting · Medical College of Wisconsin · Milwaukee, Wisconsin
- Joint Patient and Caregiver Intervention for Older African Americans With Type 2 DiabetesRecruiting · Medical College of Wisconsin · Milwaukee, Wisconsin
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)PHASE3 · Recruiting · Eli Lilly and Company · Tucson, Arizona
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightPHASE3 · Recruiting · Novo Nordisk A/S · Birmingham, Alabama